These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


875 related items for PubMed ID: 9589220

  • 21. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 22. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat.
    Rajakumar N, Laurier L, Niznik HB, Stoessl AJ.
    Synapse; 1997 Jul; 26(3):199-208. PubMed ID: 9183809
    [Abstract] [Full Text] [Related]

  • 23. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G, Zhou LW, Morabito M, Zhang SP, Weiss B.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [Abstract] [Full Text] [Related]

  • 24. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 25. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA, Mitrovic I, Battaglia G, Napier TC.
    Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
    [Abstract] [Full Text] [Related]

  • 26. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 27. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA, Wüllner U, Heneka MT, Schulz JB, Kunow M, Wachtel H, Klockgether T.
    Synapse; 1997 Aug 13; 26(4):381-91. PubMed ID: 9215597
    [Abstract] [Full Text] [Related]

  • 28. Receptor subtype-specific dopaminergic agents and unconditioned behavior.
    Beninger RJ, Mazurski EJ, Hoffman DC.
    Pol J Pharmacol Pharm; 1991 Aug 13; 43(6):507-28. PubMed ID: 1687945
    [Abstract] [Full Text] [Related]

  • 29. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J, Vargas G, Morales-Medina JC, Rivera G, De La Cruz F, Zamudio S, Flores G.
    Synapse; 2008 Jan 13; 62(1):40-9. PubMed ID: 17957737
    [Abstract] [Full Text] [Related]

  • 30. Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions.
    Neal-Beliveau BS, Joyce JN.
    Neurotoxicol Teratol; 1999 Jan 13; 21(2):129-40. PubMed ID: 10192273
    [Abstract] [Full Text] [Related]

  • 31. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats.
    Pinna A, Di Chiara G.
    Behav Pharmacol; 1998 Feb 13; 9(1):15-21. PubMed ID: 9832944
    [Abstract] [Full Text] [Related]

  • 32. Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias.
    Delfino MA, Stefano AV, Ferrario JE, Taravini IR, Murer MG, Gershanik OS.
    Behav Brain Res; 2004 Jul 09; 152(2):297-306. PubMed ID: 15196797
    [Abstract] [Full Text] [Related]

  • 33. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 09; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 34. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE, Johnson KB, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1993 May 09; 265(2):1001-10. PubMed ID: 8098756
    [Abstract] [Full Text] [Related]

  • 35. Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C, Kamdar DP, Walker PD.
    Synapse; 2003 Nov 09; 50(2):164-70. PubMed ID: 12923819
    [Abstract] [Full Text] [Related]

  • 36. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK, Platt DM, Yao WD, Spealman RD.
    J Pharmacol Exp Ther; 2007 Jun 09; 321(3):1135-43. PubMed ID: 17351103
    [Abstract] [Full Text] [Related]

  • 37. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC, Maslowski-Cobuzzi RJ.
    Synapse; 1994 Jul 09; 17(3):160-6. PubMed ID: 7974198
    [Abstract] [Full Text] [Related]

  • 38. Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems.
    Sivam SP, Cox J.
    Brain Res; 2006 Feb 16; 1073-1074():159-63. PubMed ID: 16455064
    [Abstract] [Full Text] [Related]

  • 39. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
    Boldry RC, Chase TN, Engber TM.
    J Pharmacol Exp Ther; 1993 Dec 16; 267(3):1454-9. PubMed ID: 7903390
    [Abstract] [Full Text] [Related]

  • 40. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR, Napier TC, Mueller RA.
    J Pharmacol Exp Ther; 1985 Aug 16; 234(2):447-55. PubMed ID: 3926987
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 44.